High-Net-Worth Annual Fee-Based Longevity Clinic

📌 Background

With the maturation of telomere testing technology and the marketing of NAD+ infusions as 'anti-aging,' 2026 has seen an influx of capital into anti-aging medicine. The willingness of high-net-worth individuals to pay for extended healthspans has driven the convergence of biohacking and traditional medical aesthetics. Controversy has followed: media reports have labeled the 6,800 RMB per session NAD+ treatment as a 'scam' (based on media investigations, not independently verified), yet local longevity centers continue to open in Beijing and Shanghai.

👤 Target Customers

High-net-worth individuals and their families; affluent populations willing to pay annual fees for comprehensive health management.

💰 Revenue Streams

1) Annual membership fees, where clients pay a fixed fee for a full suite of services including telomere testing, NAD+ infusions, and genetic analysis; 2) High-priced individual treatment sessions and pharmaceutical sales, such as the 6,800 RMB NAD+ infusion; 3) Commissions from the distribution of related health products (e.g., Niagen NAD+ supplements).

🧮 Cost Structure

1. Procurement of high-end laboratory and testing equipment. 2. NAD+ raw materials and associated infusion consumables. 3. Salaries for professional physicians, nutritionists, and customer service teams. 4. Rent and renovation costs for physical clinics.

🛡️ Moat

Possession of proprietary telomere longevity testing standards and technical licensing from Swiss CLP, creating differentiated testing reports; exclusive supply contracts with global NAD+ suppliers to ensure product quality and supply chain security.

🔑 Keys to Success

• Precision telomere + NAD+ testing system
• Membership-based end-to-end health management services
• Technical cooperation with international research institutions

⚠️ Risks

• Regulatory risk: Anti-aging drugs may be subject to strict medical innovation approval processes.
• Technological disruption risk: Future, more affordable gene editing or cell therapies could impact existing services.
• Customer churn due to high-price positioning.

🏢 Cases

• Beijing Longevity Center (Swiss CLP localization project)
• Tru Niagen's NAD+ supplement business empire

📊 SWOT Analysis